Forget-me-nots in the care of children with retinoblastoma

Seminars in Ophthalmology

Volumn 23, Issue 5-6, 2008, Pages 324-334

  Shields, Carol L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cancer; Children; Eye; Pediatric; Retina; Retinoblastoma

Indexed keywords

CARBOPLATIN; ETOPOSIDE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD CARE; CLINICAL TRIAL; CRYOTHERAPY; DISEASE SEVERITY; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; EYE TUMOR; FOLLOW UP; GENE MUTATION; GERM LINE; HUMAN; HYPERTHERMIC THERAPY; METASTASIS; OPHTHALMOLOGY; PINEAL BODY TUMOR; PRIORITY JOURNAL; RETINA; RETINA TUMOR; RETINOBLASTOMA; REVIEW; SECOND CANCER; SUBRETINAL FLUID; TREATMENT FAILURE; VISUAL ACUITY; VITREOUS BODY;

CHILD; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; NEOPLASMS, SECOND PRIMARY; RETINAL NEOPLASMS; RETINOBLASTOMA; RISK FACTORS;

EID: 57649129028     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530802506029     Document Type: Review

References (27)

1. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 2006;17:228-234.
2. Shields JA, Shields CL. Retinoblastoma. In Shields JA, Shields CL, Atlas of Intraocular Tumors. Philadelphia: LipincottWilliamsWilkins, 2008, 293-365.
3. Shields JA, Shields CL. Management and prognosis of retinoblastoma. In Intraocular Tumors. A Text and Atlas. Philadelphia: WB Saunders, 1992, 377-392.
4. Rodrigues KE, Latorre Mdo R, de Camargo B. Delayed diagnosis in retinoblastoma. J Pediatr (Rio J). 2004;80:511-6.
5. Nichols KE, Houseknecht MD, Godmilow L, Bunin G, Shields C, Meadows A, Ganguly A. Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene. Hum Mutat. 2005;25:566-74.
6. Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical riskfactors. Cancer. 1994;73:692-8.
7. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77:544-8.
8. Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, Shields JA. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120:923-31.
9. Kivela T. Trilateral retinoblastoma: A meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 1999;17: 1829-1837.
10. De Potter P, Shields CL, Shields JA. Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus. 1994;31:26-31.
11. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119:1269-72.
12. Karatza E, Shields CL, Flanders AE, Gonzalez ME, Shields JA. Pineal cyst simulating pinealoblastoma in 11 children with retinoblastoma. Arch Ophthalmol 2006;124:595-7.
13. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988;95:1583-7.
14. Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr, Li FP. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278:1262-1267.
15. Abramson DH, Melson MR, Dunkel IJ, Frank CM. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology. 2001;108:1868-76.
16. Gombos DS, Hungerford J, Abramson DH, et al. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology. 2007 Jul;114(7):1378-83.
17. Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 200;18:41-53, viii.
18. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006;113:2276-80.
19. Epstein J, Shields CL, Shields JA. Trends in the management of retinoblastoma; Evaluation of 1,196 consecutive eyes during 1974-2001. J Pediatr Ophthalmol Strab 2003;40:196-203.
20. Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemoreduction. Retina. 2004;24:849-62.
21. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ. Factors predictive of recurrence of retinal tumor, vitreous seeds and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002;120:460-4.
22. Shields CL, Honavar SG Meadows AT, Shields JA, Demirci H, Singh AD, Friedman D, Naduvilaths TJ. Chemoreduction plus focal therapy for retinoblastoma: Factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-664.
23. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma Analysis of tumor control and risks for recurrence in 457 tumors.AmJ Ophthalmol 2004;138:329-37.
24. Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA. Macular retinoblastoma managed with chemoreduction. Analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Arch Ophthalmol 2005;123:765-73.
25. Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors. Ophthalmology 2006;113:2087-92.
26. Shields CL, Honavar S, Shields JA, Demirci H, Meadows AT. Vitrectomy in eyes with unsuspected retinoblastoma. Ophthalmology 2000;107:2250-5.
27. Shields CL, Uysal Y, Marr BP, Lally DE, Rodriques E, Kharod B, Shields JA. Experience with the polymer-coated hydroxyapatite implant following enucleation in 126 patients. Ophthalmology2007;114:367-73.